ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
174 hedge funds and large institutions have $291M invested in Antares Pharma, Inc. in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 53 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
174
Holders Change
+10
Holders Change %
+6.1%
% of All Funds
3.09%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
23
Increased
50
Reduced
53
Closed
13
Calls
$595K
Puts
$1.45M
Net Calls
-$853K
Net Calls Change
-$333K
Top Buyers
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
$14.2M |
| 2 |
CWM
Centric Wealth Management
Chicago,
Illinois
|
$13.9M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
$2.39M |
| 4 |
Morgan Stanley
New York
|
$2.49M |
| 5 |
BlackRock
New York
|
$47.2M |
